Showing results (31-40 of 165) with videos related to
Sort By:
Pageof 17
Stem Cell Reports|December 5, 2025
Cross-modal integration of metabolomics and cardiac functionality captures dynamic metabotoxic effects of doxorubicin in engineered heart tissuesFederica Conte, Doroteya K Staykova, Carla Cofiño-Fabres, et al.JIMD Reports|November 20, 2019
A mutation in mannose-phosphate-dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathyWalinka van Tol, Angel Ashikov, Eckhard Korsch, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|February 6, 2002
Synthesis of fragments of the glycocalyx glycan of the parasite Schistosoma mansoniKároly Agoston, Janos Kerékgyártó, János Hajkó, et al.Expert Review of Molecular Diagnostics|February 15, 2014
Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylationDavid F G J Wolthuis, Miriam C Janssen, David Cassiman, et al.Analytical Chemistry|May 22, 2024
Maximizing Glycoproteomics Results through an Integrated Parallel Accumulation Serial Fragmentation WorkflowMelissa Baerenfaenger, Merel A Post, Fokje Zijlstra, et al.Journal of Neurochemistry|August 31, 2023
Sialic acid biosynthesis pathway blockade disturbs neuronal network formation in human iPSC-derived excitatory neuronsRachel Mijdam, Chantal Bijnagte-Schoenmaker, Emma Dyke, et al.Glycobiology|July 23, 2005
Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groupsSuzan Wopereis, Eva Morava, Stephanie Grünewald, et al.Clinical Chemistry|January 29, 2011
Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type IIMaïlys Guillard, Eva Morava, Floris L van Delft, et al.Bioorganic & Medicinal Chemistry|August 30, 2011
Protein enrichment by capture-release based on strain-promoted cycloaddition of azide with bicyclononyne (BCN)Rinske P Temming, Monique van Scherpenzeel, Esra te Brinke, et al.Orphanet Journal of Rare Diseases|March 21, 2021
D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trialPeter Witters, Hans Andersson, Jaak Jaeken, et al.Pageof 17